Diabetic Macular Edema Treatment Market - Global Outlook and Forecast 2022-2028
Diabetic macular edema (DME) is characterized by accumulation of fluid in the macula – a part of retina responsible for vision. Accumulation may cause by leakage of plasma constituents into the surrounding, consequently leading to edema.
This report contains market size and forecasts of Diabetic Macular Edema Treatment in Global, including the following market information:
Global Diabetic Macular Edema Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Diabetic Macular Edema Treatment market was valued at 3040.4 million in 2021 and is projected to reach US$ 3494.7 million by 2028, at a CAGR of 2.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Laser Photocoagulation Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Diabetic Macular Edema Treatment include Genentech, Novartis, GlaxoSmithKline, Eyetech Pharmaceuticals and Alimera Sciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diabetic Macular Edema Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetic Macular Edema Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Diabetic Macular Edema Treatment Market Segment Percentages, by Type, 2021 (%)
Global Diabetic Macular Edema Treatment Market Segment Percentages, by Application, 2021 (%)
Global Diabetic Macular Edema Treatment Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Diabetic Macular Edema Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Diabetic Macular Edema Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Diabetic Macular Edema Treatment in Global, including the following market information:
Global Diabetic Macular Edema Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Diabetic Macular Edema Treatment market was valued at 3040.4 million in 2021 and is projected to reach US$ 3494.7 million by 2028, at a CAGR of 2.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Laser Photocoagulation Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Diabetic Macular Edema Treatment include Genentech, Novartis, GlaxoSmithKline, Eyetech Pharmaceuticals and Alimera Sciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diabetic Macular Edema Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetic Macular Edema Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Diabetic Macular Edema Treatment Market Segment Percentages, by Type, 2021 (%)
- Laser Photocoagulation Therapy
- Pharmacological Therapy
- Bevacizumab
- Ranibizumab
- Triamcinolone
Global Diabetic Macular Edema Treatment Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Ophthalmic Clinics
- Research Institutes
- Contract Research Organizations
Global Diabetic Macular Edema Treatment Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Diabetic Macular Edema Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Diabetic Macular Edema Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Genentech
- Novartis
- GlaxoSmithKline
- Eyetech Pharmaceuticals
- Alimera Sciences
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Diabetic Macular Edema Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Diabetic Macular Edema Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL DIABETIC MACULAR EDEMA TREATMENT OVERALL MARKET SIZE
2.1 Global Diabetic Macular Edema Treatment Market Size: 2021 VS 2028
2.2 Global Diabetic Macular Edema Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Diabetic Macular Edema Treatment Players in Global Market
3.2 Top Global Diabetic Macular Edema Treatment Companies Ranked by Revenue
3.3 Global Diabetic Macular Edema Treatment Revenue by Companies
3.4 Top 3 and Top 5 Diabetic Macular Edema Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Diabetic Macular Edema Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Diabetic Macular Edema Treatment Players in Global Market
3.6.1 List of Global Tier 1 Diabetic Macular Edema Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Diabetic Macular Edema Treatment Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Diabetic Macular Edema Treatment Market Size Markets, 2021 & 2028
4.1.2 Laser Photocoagulation Therapy
4.1.3 Pharmacological Therapy
4.1.4 Bevacizumab
4.1.5 Ranibizumab
4.1.6 Triamcinolone
4.2 By Type - Global Diabetic Macular Edema Treatment Revenue & Forecasts
4.2.1 By Type - Global Diabetic Macular Edema Treatment Revenue, 2017-2022
4.2.2 By Type - Global Diabetic Macular Edema Treatment Revenue, 2023-2028
4.2.3 By Type - Global Diabetic Macular Edema Treatment Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Diabetic Macular Edema Treatment Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Ophthalmic Clinics
5.1.4 Research Institutes
5.1.5 Contract Research Organizations
5.2 By Application - Global Diabetic Macular Edema Treatment Revenue & Forecasts
5.2.1 By Application - Global Diabetic Macular Edema Treatment Revenue, 2017-2022
5.2.2 By Application - Global Diabetic Macular Edema Treatment Revenue, 2023-2028
5.2.3 By Application - Global Diabetic Macular Edema Treatment Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Diabetic Macular Edema Treatment Market Size, 2021 & 2028
6.2 By Region - Global Diabetic Macular Edema Treatment Revenue & Forecasts
6.2.1 By Region - Global Diabetic Macular Edema Treatment Revenue, 2017-2022
6.2.2 By Region - Global Diabetic Macular Edema Treatment Revenue, 2023-2028
6.2.3 By Region - Global Diabetic Macular Edema Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Diabetic Macular Edema Treatment Revenue, 2017-2028
6.3.2 US Diabetic Macular Edema Treatment Market Size, 2017-2028
6.3.3 Canada Diabetic Macular Edema Treatment Market Size, 2017-2028
6.3.4 Mexico Diabetic Macular Edema Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Diabetic Macular Edema Treatment Revenue, 2017-2028
6.4.2 Germany Diabetic Macular Edema Treatment Market Size, 2017-2028
6.4.3 France Diabetic Macular Edema Treatment Market Size, 2017-2028
6.4.4 U.K. Diabetic Macular Edema Treatment Market Size, 2017-2028
6.4.5 Italy Diabetic Macular Edema Treatment Market Size, 2017-2028
6.4.6 Russia Diabetic Macular Edema Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Diabetic Macular Edema Treatment Market Size, 2017-2028
6.4.8 Benelux Diabetic Macular Edema Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Diabetic Macular Edema Treatment Revenue, 2017-2028
6.5.2 China Diabetic Macular Edema Treatment Market Size, 2017-2028
6.5.3 Japan Diabetic Macular Edema Treatment Market Size, 2017-2028
6.5.4 South Korea Diabetic Macular Edema Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Diabetic Macular Edema Treatment Market Size, 2017-2028
6.5.6 India Diabetic Macular Edema Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Diabetic Macular Edema Treatment Revenue, 2017-2028
6.6.2 Brazil Diabetic Macular Edema Treatment Market Size, 2017-2028
6.6.3 Argentina Diabetic Macular Edema Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Diabetic Macular Edema Treatment Revenue, 2017-2028
6.7.2 Turkey Diabetic Macular Edema Treatment Market Size, 2017-2028
6.7.3 Israel Diabetic Macular Edema Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Diabetic Macular Edema Treatment Market Size, 2017-2028
6.7.5 UAE Diabetic Macular Edema Treatment Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Genentech
7.1.1 Genentech Corporate Summary
7.1.2 Genentech Business Overview
7.1.3 Genentech Diabetic Macular Edema Treatment Major Product Offerings
7.1.4 Genentech Diabetic Macular Edema Treatment Revenue in Global Market (2017-2022)
7.1.5 Genentech Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Diabetic Macular Edema Treatment Major Product Offerings
7.2.4 Novartis Diabetic Macular Edema Treatment Revenue in Global Market (2017-2022)
7.2.5 Novartis Key News
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Corporate Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Diabetic Macular Edema Treatment Major Product Offerings
7.3.4 GlaxoSmithKline Diabetic Macular Edema Treatment Revenue in Global Market (2017-2022)
7.3.5 GlaxoSmithKline Key News
7.4 Eyetech Pharmaceuticals
7.4.1 Eyetech Pharmaceuticals Corporate Summary
7.4.2 Eyetech Pharmaceuticals Business Overview
7.4.3 Eyetech Pharmaceuticals Diabetic Macular Edema Treatment Major Product Offerings
7.4.4 Eyetech Pharmaceuticals Diabetic Macular Edema Treatment Revenue in Global Market (2017-2022)
7.4.5 Eyetech Pharmaceuticals Key News
7.5 Alimera Sciences
7.5.1 Alimera Sciences Corporate Summary
7.5.2 Alimera Sciences Business Overview
7.5.3 Alimera Sciences Diabetic Macular Edema Treatment Major Product Offerings
7.5.4 Alimera Sciences Diabetic Macular Edema Treatment Revenue in Global Market (2017-2022)
7.5.5 Alimera Sciences Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Diabetic Macular Edema Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Diabetic Macular Edema Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL DIABETIC MACULAR EDEMA TREATMENT OVERALL MARKET SIZE
2.1 Global Diabetic Macular Edema Treatment Market Size: 2021 VS 2028
2.2 Global Diabetic Macular Edema Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Diabetic Macular Edema Treatment Players in Global Market
3.2 Top Global Diabetic Macular Edema Treatment Companies Ranked by Revenue
3.3 Global Diabetic Macular Edema Treatment Revenue by Companies
3.4 Top 3 and Top 5 Diabetic Macular Edema Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Diabetic Macular Edema Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Diabetic Macular Edema Treatment Players in Global Market
3.6.1 List of Global Tier 1 Diabetic Macular Edema Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Diabetic Macular Edema Treatment Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Diabetic Macular Edema Treatment Market Size Markets, 2021 & 2028
4.1.2 Laser Photocoagulation Therapy
4.1.3 Pharmacological Therapy
4.1.4 Bevacizumab
4.1.5 Ranibizumab
4.1.6 Triamcinolone
4.2 By Type - Global Diabetic Macular Edema Treatment Revenue & Forecasts
4.2.1 By Type - Global Diabetic Macular Edema Treatment Revenue, 2017-2022
4.2.2 By Type - Global Diabetic Macular Edema Treatment Revenue, 2023-2028
4.2.3 By Type - Global Diabetic Macular Edema Treatment Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Diabetic Macular Edema Treatment Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Ophthalmic Clinics
5.1.4 Research Institutes
5.1.5 Contract Research Organizations
5.2 By Application - Global Diabetic Macular Edema Treatment Revenue & Forecasts
5.2.1 By Application - Global Diabetic Macular Edema Treatment Revenue, 2017-2022
5.2.2 By Application - Global Diabetic Macular Edema Treatment Revenue, 2023-2028
5.2.3 By Application - Global Diabetic Macular Edema Treatment Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Diabetic Macular Edema Treatment Market Size, 2021 & 2028
6.2 By Region - Global Diabetic Macular Edema Treatment Revenue & Forecasts
6.2.1 By Region - Global Diabetic Macular Edema Treatment Revenue, 2017-2022
6.2.2 By Region - Global Diabetic Macular Edema Treatment Revenue, 2023-2028
6.2.3 By Region - Global Diabetic Macular Edema Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Diabetic Macular Edema Treatment Revenue, 2017-2028
6.3.2 US Diabetic Macular Edema Treatment Market Size, 2017-2028
6.3.3 Canada Diabetic Macular Edema Treatment Market Size, 2017-2028
6.3.4 Mexico Diabetic Macular Edema Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Diabetic Macular Edema Treatment Revenue, 2017-2028
6.4.2 Germany Diabetic Macular Edema Treatment Market Size, 2017-2028
6.4.3 France Diabetic Macular Edema Treatment Market Size, 2017-2028
6.4.4 U.K. Diabetic Macular Edema Treatment Market Size, 2017-2028
6.4.5 Italy Diabetic Macular Edema Treatment Market Size, 2017-2028
6.4.6 Russia Diabetic Macular Edema Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Diabetic Macular Edema Treatment Market Size, 2017-2028
6.4.8 Benelux Diabetic Macular Edema Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Diabetic Macular Edema Treatment Revenue, 2017-2028
6.5.2 China Diabetic Macular Edema Treatment Market Size, 2017-2028
6.5.3 Japan Diabetic Macular Edema Treatment Market Size, 2017-2028
6.5.4 South Korea Diabetic Macular Edema Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Diabetic Macular Edema Treatment Market Size, 2017-2028
6.5.6 India Diabetic Macular Edema Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Diabetic Macular Edema Treatment Revenue, 2017-2028
6.6.2 Brazil Diabetic Macular Edema Treatment Market Size, 2017-2028
6.6.3 Argentina Diabetic Macular Edema Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Diabetic Macular Edema Treatment Revenue, 2017-2028
6.7.2 Turkey Diabetic Macular Edema Treatment Market Size, 2017-2028
6.7.3 Israel Diabetic Macular Edema Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Diabetic Macular Edema Treatment Market Size, 2017-2028
6.7.5 UAE Diabetic Macular Edema Treatment Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Genentech
7.1.1 Genentech Corporate Summary
7.1.2 Genentech Business Overview
7.1.3 Genentech Diabetic Macular Edema Treatment Major Product Offerings
7.1.4 Genentech Diabetic Macular Edema Treatment Revenue in Global Market (2017-2022)
7.1.5 Genentech Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Diabetic Macular Edema Treatment Major Product Offerings
7.2.4 Novartis Diabetic Macular Edema Treatment Revenue in Global Market (2017-2022)
7.2.5 Novartis Key News
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Corporate Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Diabetic Macular Edema Treatment Major Product Offerings
7.3.4 GlaxoSmithKline Diabetic Macular Edema Treatment Revenue in Global Market (2017-2022)
7.3.5 GlaxoSmithKline Key News
7.4 Eyetech Pharmaceuticals
7.4.1 Eyetech Pharmaceuticals Corporate Summary
7.4.2 Eyetech Pharmaceuticals Business Overview
7.4.3 Eyetech Pharmaceuticals Diabetic Macular Edema Treatment Major Product Offerings
7.4.4 Eyetech Pharmaceuticals Diabetic Macular Edema Treatment Revenue in Global Market (2017-2022)
7.4.5 Eyetech Pharmaceuticals Key News
7.5 Alimera Sciences
7.5.1 Alimera Sciences Corporate Summary
7.5.2 Alimera Sciences Business Overview
7.5.3 Alimera Sciences Diabetic Macular Edema Treatment Major Product Offerings
7.5.4 Alimera Sciences Diabetic Macular Edema Treatment Revenue in Global Market (2017-2022)
7.5.5 Alimera Sciences Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Diabetic Macular Edema Treatment Market Opportunities & Trends in Global Market
Table 2. Diabetic Macular Edema Treatment Market Drivers in Global Market
Table 3. Diabetic Macular Edema Treatment Market Restraints in Global Market
Table 4. Key Players of Diabetic Macular Edema Treatment in Global Market
Table 5. Top Diabetic Macular Edema Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Diabetic Macular Edema Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Diabetic Macular Edema Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Diabetic Macular Edema Treatment Product Type
Table 9. List of Global Tier 1 Diabetic Macular Edema Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diabetic Macular Edema Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Diabetic Macular Edema Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Diabetic Macular Edema Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Diabetic Macular Edema Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Diabetic Macular Edema Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Diabetic Macular Edema Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Diabetic Macular Edema Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Genentech Corporate Summary
Table 31. Genentech Diabetic Macular Edema Treatment Product Offerings
Table 32. Genentech Diabetic Macular Edema Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis Diabetic Macular Edema Treatment Product Offerings
Table 35. Novartis Diabetic Macular Edema Treatment Revenue (US$, Mn), (2017-2022)
Table 36. GlaxoSmithKline Corporate Summary
Table 37. GlaxoSmithKline Diabetic Macular Edema Treatment Product Offerings
Table 38. GlaxoSmithKline Diabetic Macular Edema Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Eyetech Pharmaceuticals Corporate Summary
Table 40. Eyetech Pharmaceuticals Diabetic Macular Edema Treatment Product Offerings
Table 41. Eyetech Pharmaceuticals Diabetic Macular Edema Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Alimera Sciences Corporate Summary
Table 43. Alimera Sciences Diabetic Macular Edema Treatment Product Offerings
Table 44. Alimera Sciences Diabetic Macular Edema Treatment Revenue (US$, Mn), (2017-2022)
Table 1. Diabetic Macular Edema Treatment Market Opportunities & Trends in Global Market
Table 2. Diabetic Macular Edema Treatment Market Drivers in Global Market
Table 3. Diabetic Macular Edema Treatment Market Restraints in Global Market
Table 4. Key Players of Diabetic Macular Edema Treatment in Global Market
Table 5. Top Diabetic Macular Edema Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Diabetic Macular Edema Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Diabetic Macular Edema Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Diabetic Macular Edema Treatment Product Type
Table 9. List of Global Tier 1 Diabetic Macular Edema Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diabetic Macular Edema Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Diabetic Macular Edema Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Diabetic Macular Edema Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Diabetic Macular Edema Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Diabetic Macular Edema Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Diabetic Macular Edema Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Diabetic Macular Edema Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Genentech Corporate Summary
Table 31. Genentech Diabetic Macular Edema Treatment Product Offerings
Table 32. Genentech Diabetic Macular Edema Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis Diabetic Macular Edema Treatment Product Offerings
Table 35. Novartis Diabetic Macular Edema Treatment Revenue (US$, Mn), (2017-2022)
Table 36. GlaxoSmithKline Corporate Summary
Table 37. GlaxoSmithKline Diabetic Macular Edema Treatment Product Offerings
Table 38. GlaxoSmithKline Diabetic Macular Edema Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Eyetech Pharmaceuticals Corporate Summary
Table 40. Eyetech Pharmaceuticals Diabetic Macular Edema Treatment Product Offerings
Table 41. Eyetech Pharmaceuticals Diabetic Macular Edema Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Alimera Sciences Corporate Summary
Table 43. Alimera Sciences Diabetic Macular Edema Treatment Product Offerings
Table 44. Alimera Sciences Diabetic Macular Edema Treatment Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Diabetic Macular Edema Treatment Segment by Type in 2021
Figure 2. Diabetic Macular Edema Treatment Segment by Application in 2021
Figure 3. Global Diabetic Macular Edema Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Diabetic Macular Edema Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Diabetic Macular Edema Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Diabetic Macular Edema Treatment Revenue in 2021
Figure 8. By Type - Global Diabetic Macular Edema Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Diabetic Macular Edema Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Diabetic Macular Edema Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Diabetic Macular Edema Treatment Revenue Market Share, 2017-2028
Figure 12. US Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Diabetic Macular Edema Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Diabetic Macular Edema Treatment Revenue Market Share, 2017-2028
Figure 24. China Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Diabetic Macular Edema Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Diabetic Macular Edema Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Genentech Diabetic Macular Edema Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Diabetic Macular Edema Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GlaxoSmithKline Diabetic Macular Edema Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Eyetech Pharmaceuticals Diabetic Macular Edema Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Alimera Sciences Diabetic Macular Edema Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Diabetic Macular Edema Treatment Segment by Type in 2021
Figure 2. Diabetic Macular Edema Treatment Segment by Application in 2021
Figure 3. Global Diabetic Macular Edema Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Diabetic Macular Edema Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Diabetic Macular Edema Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Diabetic Macular Edema Treatment Revenue in 2021
Figure 8. By Type - Global Diabetic Macular Edema Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Diabetic Macular Edema Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Diabetic Macular Edema Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Diabetic Macular Edema Treatment Revenue Market Share, 2017-2028
Figure 12. US Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Diabetic Macular Edema Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Diabetic Macular Edema Treatment Revenue Market Share, 2017-2028
Figure 24. China Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Diabetic Macular Edema Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Diabetic Macular Edema Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Diabetic Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Genentech Diabetic Macular Edema Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Diabetic Macular Edema Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GlaxoSmithKline Diabetic Macular Edema Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Eyetech Pharmaceuticals Diabetic Macular Edema Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Alimera Sciences Diabetic Macular Edema Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)